Showing recent highlights
What's New
PubMed · December 1, 2026
Researchers found that for people who had a stroke caused by a blocked artery at the base of the brain but had only mild symptoms, a procedure called endovascular thrombectomy — where doctors thread a tiny tool through a blood vessel to physically remove the clot — appeared to lead to better recovery compared to medication alone, without increasing the risk of bleeding in the brain or death. This matters because doctors have been uncertain whether this procedure is worth doing when stroke symptoms are mild, so these findings could help guide future decisions about treatment. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 11, 2026
Researchers found that people with long-term arm and hand weakness after a stroke who received vagus nerve stimulation — a therapy that gently activates a nerve in the neck to help the brain recover — continued to show meaningful improvements in arm movement and daily function even two years after treatment. Participants also reported better quality of life and ability to take part in everyday activities, with some still showing gains at three years. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 11, 2026
Researchers found that for people having a procedure to remove a blood clot from a blocked brain artery during a stroke, using general anesthesia — where the patient is fully unconscious — may lead to better chances of regaining independence compared to lighter sedation where the patient stays awake or lightly asleep. This matters because doctors have long debated which approach is safer and more effective, and this analysis used a newer statistical method to look at all the best available studies together, finding stronger hints of benefit from full anesthesia than earlier analyses did. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 11, 2026
Researchers found that giving clot-busting medication (called IV thrombolysis) to stroke patients up to 24 hours after their symptoms began — rather than the usual 4.5-hour window — may still help more people recover well and regain independence. This matters because many stroke patients don't reach the hospital within that earlier window, so expanding when treatment can be given could potentially help a larger group of people. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 11, 2026
Researchers found that for people who had a stroke caused by a major blocked artery, a procedure to physically remove the clot (called a thrombectomy) remained just as helpful even when performed later in a 6-to-24-hour window after symptoms began — and interestingly, waiting longer without the procedure led to noticeably worse outcomes, meaning the benefit of treatment actually grew over time. This suggests that people who arrive later after a stroke may still have a lot to gain from this clot-removal procedure, which is an encouraging sign for those who don't reach the hospital quickly. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · August 11, 2026
Researchers found that for people having an ischemic stroke — the kind caused by a blood clot blocking blood flow to the brain — a clot-dissolving treatment called IV thrombolysis may still be helpful even when given more than 4.5 hours after symptoms began, which is longer than the window doctors have traditionally used. The analysis of 13 studies involving thousands of patients suggested that carefully selected patients treated in this extended timeframe had better chances of recovering well, though there was also a higher risk of bleeding in the brain, so doctors would need to weigh the benefits and risks for each person individually. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 28, 2026
Researchers found that a clot-dissolving treatment given through an IV — commonly used after certain strokes — did not clearly help people who had a minor stroke recover better, and was actually linked to a higher chance of bleeding in the brain and death within 90 days compared to standard care without that treatment. This raises questions about whether this approach is the right choice for people whose strokes are considered less severe. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 28, 2026
Researchers found that people who had a mild stroke or a brief "warning stroke" (called a TIA, where stroke-like symptoms appear and then quickly go away) were less likely to have another stroke within 90 days if they took two blood-thinning medications together — clopidogrel and aspirin — compared to aspirin alone. The combination appeared to offer a meaningful benefit, while the timing of adding a cholesterol-lowering medication (a statin) made less of a difference on its own. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether the patient should take both clopidogrel and aspirin together, along with a high-dose statin right away, if the patient has a mild stroke or TIA.
What's New
PubMed · July 24, 2026
A study found that stroke survivors who did a single session of moderate-intensity aerobic exercise — think cycling at a pace where talking feels a bit challenging — had a notable rise in a brain protein called BDNF (brain-derived neurotrophic factor), which helps the brain heal and adapt after injury. This is interesting because boosting this protein through exercise could potentially support recovery of brain function following a stroke. This is early research and hasn't yet changed treatment guidelines.
Guidelines
ScienceDaily · July 22, 2026
A review by the American Heart Association found that up to 400 milligrams of caffeine a day — about three to five cups of regular black coffee — appears to be generally safe for the heart and may even be linked to lower chances of heart disease, stroke, and Type 2 diabetes. However, the source of caffeine matters a lot: highly concentrated energy drinks and shots were linked to raised blood pressure and irregular heartbeats, which can be dangerous. People with heart failure or other heart conditions may want to talk with their doctor before making changes to their caffeine habits.
What's New
PubMed · July 21, 2026
A study found that for people who had a stroke caused by a blockage in a smaller, harder-to-reach blood vessel in the brain, a procedure called thrombectomy — where doctors use a tiny device to physically remove the clot — did not clearly improve outcomes compared to standard medical treatment alone. Researchers looked at data from 37 studies involving over 12,000 patients and found no significant difference in recovery or survival between those who had the procedure and those who didn't. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 18, 2026
Researchers found that giving a blood-thinning medication called tirofiban — which helps prevent clots from forming — right after a stroke procedure called thrombectomy (where doctors physically remove a blood clot from the brain) led to more patients being able to function independently 90 days later, compared to those who received a placebo. This matters because even when the clot-removal procedure goes well, many stroke patients still struggle to recover fully afterward, so finding a medication that might help bridge that gap is significant. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed (Open Access Guidelines) · July 15, 2026
Researchers found that giving a clot-dissolving drug (called thrombolysis) before a procedure to physically remove a blood clot from a large brain artery — a treatment for a serious type of stroke — was linked to better odds of recovering well and surviving at 90 days. However, this combination also raised the risk of bleeding inside the brain, which is a serious complication. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 11, 2026
Researchers found that stroke survivors who experienced memory and thinking problems afterward showed greater improvement when they received scalp acupuncture and injections of a nerve-supporting protein (called nerve growth factor) alongside standard cognitive training, compared to those who received training alone or training plus acupuncture. The combination group scored notably better on thinking ability, independence in daily tasks, and physical movement after four weeks. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 10, 2026
Researchers found that combining two rehabilitation techniques — one that uses mild electrical stimulation applied to the scalp (called tDCS) and another that uses a mirror to trick the brain into thinking a weakened arm is moving normally (called mirror therapy) — may help stroke patients regain movement and function in their arms. The combined approach also seemed to help people with everyday tasks like dressing or eating, and the benefits appeared even stronger for people in the early weeks after a stroke. This is early research and hasn't yet changed treatment guidelines.
Guidelines
PubMed (Guideline Reviews) · July 9, 2026
According to the American Heart Association and American Stroke Association (AHA/ASA) guidelines, people who have had a stroke should receive fast, protocol-driven care — things like early recognition of stroke symptoms and basic supportive treatment — which can make a real difference in outcomes even in settings with limited resources. However, some recommended treatments, like advanced brain scans or a procedure to remove blood clots from brain arteries (called endovascular thrombectomy), require specialized equipment and trained specialists that aren't always available everywhere. This matters because it highlights that while some stroke care steps are practical almost anywhere, others depend heavily on what a particular hospital or health system is able to offer.
What's New
PubMed · July 8, 2026
Researchers found that a specialized stroke treatment tool called the Route 92 Reperfusion System — which uses wider-than-usual catheters (thin flexible tubes) to physically remove blood clots from blocked brain arteries — was more effective at clearing those clots on the first attempt compared to other similar tools. In the studies reviewed, about 94% of patients treated with this system had their blood flow successfully restored, and 43% were able to live independently afterward. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 7, 2026
Researchers found that a drug called nerinetide, designed to protect brain cells after a stroke, didn't show an overall benefit for stroke patients at one year when compared to a placebo — but there was an interesting detail: among patients who received the drug within three hours of their stroke, nearly twice as many regained the ability to function independently and had better survival rates compared to those who got a placebo. This suggests that timing might play a big role in whether the drug could help, and researchers are still trying to understand what that means. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 6, 2026
Researchers found that among more than 3,000 people who had recently experienced a stroke or a mini-stroke (a brief stroke-like episode that serves as a warning sign), a striking 70% were not hitting the current blood pressure target recommended to help prevent another stroke — meaning their high blood pressure was not well enough controlled. Older age, a prior history of high blood pressure, and a specific type of stroke called a lacunar stroke (caused by a blockage in a small blood vessel deep in the brain) were all linked to a greater chance of missing that target. This matters because high blood pressure is one of the biggest controllable risk factors for having another stroke, so understanding who falls short of targets could help focus care. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 2, 2026
Researchers found that stroke survivors were generally willing to use a video game-based tool called the Neurofenix platform to help rehabilitate their arm and hand — both in the hospital and at home — after a stroke. Participants ranged from those with mild to severe arm weakness, and most found the technology acceptable, meaning it felt manageable and worthwhile to them. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 1, 2026
Researchers found that people recovering from a stroke often walk unevenly — spending different amounts of time on each foot — and that this uneven walking pattern is linked to being less stable and more likely to fall sideways. The study suggests this lopsided walking style may actually be the body's way of compensating for poor balance on the weaker side, but it may create new risks on the stronger side. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 1, 2026
Researchers found that liraglutide — a diabetes medication like Ozempic or Victoza — may be especially helpful at reducing repeat strokes in people with type 2 diabetes who also have high insulin resistance, meaning their body doesn't respond well to the insulin it makes. In the study, people with high insulin resistance who took liraglutide had notably fewer repeat strokes compared to those who only received standard care. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 1, 2026
Researchers found that rehabilitation programs led by nurses — rather than the usual care team — helped stroke survivors feel better in several meaningful ways, including less depression, less pain, and improved ability to handle daily tasks like dressing and bathing. These improvements could matter a lot for stroke survivors, since recovery often extends well beyond the hospital and into everyday life. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 1, 2026
A study found that stroke patients who received a brain stimulation technique called rTMS — which uses magnetic pulses to gently activate a specific area of the brain involved in thinking and planning — along with exercises that combined walking and mental tasks at the same time, showed better improvements in balance, mobility, and thinking skills compared to those who did not receive the real stimulation. This matters for people who have had a stroke because recovering the ability to walk safely while also thinking (like navigating a busy street) is a real everyday challenge, and finding ways to speed up that recovery could meaningfully improve quality of life. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 1, 2026
A study found that using robotic therapy machines to help stroke survivors practice arm and hand movements during their hospital rehabilitation allowed patients to do 159% more repetitions — meaning far more practice attempts — per session compared to standard therapy alone. However, despite all that extra practice, patients who used the robots did not end up with noticeably better arm strength or movement than those who received conventional therapy by the end of their stay. Both patients and therapists felt the robotic therapy was worthwhile, which suggests it may still have a role in keeping people engaged and motivated during recovery. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 1, 2026
Researchers found that for people having a certain type of stroke caused by a blocked artery in the brain, the amount of time that passed before receiving clot-dissolving medication did not appear to affect how well the treatment cleared the blockage. In other words, getting the medication a little earlier or later — within the already-recommended treatment window — didn't seem to make a meaningful difference in whether the clot was successfully removed. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 1, 2026
Researchers found that combining a therapy called pulsed electromagnetic field stimulation — which uses gentle magnetic pulses to influence how cells handle calcium — with breathing muscle exercises may help improve lung function in people recovering from stroke, who often struggle to breathe fully and deeply. This small study of 27 people suggested the combination worked better than breathing exercises alone. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 1, 2026
A study found that stroke survivors who did short, supervised cycling sessions at home three times a week for eight weeks reported significantly less fatigue and had better cardiovascular fitness — meaning their heart and lungs worked more efficiently — compared to those who just followed their usual care routine. Fatigue after a stroke affects nearly half of all survivors and can make recovery much harder, so finding a practical home-based approach that helps is meaningful. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 1, 2026
Researchers found that a brain stimulation technique called high-frequency repetitive transcranial magnetic stimulation — which uses magnetic pulses to gently activate specific areas of the brain — appeared to improve memory in people who developed thinking and memory problems after a stroke. The analysis combined results from 21 studies involving over 1,700 patients, and across several different memory tests, participants who received this treatment consistently scored better than those who didn't. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 1, 2026
A study found that colchicine — a medication that's been used for decades to treat gout and inflammation — may help protect people with coronary artery disease (a condition where the heart's blood vessels become narrowed or blocked) from serious heart problems like heart attacks or strokes. Researchers found that taking a low dose (0.5 mg once daily) for more than six months appeared to preserve that heart-protective benefit while the risk of stomach and digestive side effects, which were a concern at higher doses, became much less of an issue. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether colchicine might help reduce the patient's risk of another heart attack or stroke, and whether the potential stomach problems from taking it would be worth that benefit.
For informational purposes only. Not medical advice. Always consult a physician before making any health decisions.